🇺🇸 FDA
Pipeline program

Evinacumab

R1500-CL-1643

Phase 2 small_molecule completed

Quick answer

Evinacumab for Hypercholesterolemia is a Phase 2 program (small_molecule) at Regeneron UK Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Regeneron UK Limited
Indication
Hypercholesterolemia
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials